STOCK TITAN

1933 Industries Announces Repurchase and Cancellation of Convertible Debentures

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

1933 Industries (OTCID:TGIFF), a Nevada-based cannabis company, has announced a strategic debenture repurchase agreement with two arm's length parties. The company will repurchase $475,000 in principal value of convertible debentures for $47,500 CAD, representing a significant discount.

Following the transaction's completion, expected around September 5, 2025, the outstanding debenture principal will be reduced to $2,598,000. The repurchased debentures will be cancelled and removed from the company's liabilities, demonstrating management's commitment to strengthening the balance sheet.

Loading...
Loading translation...

Positive

  • Significant 90% discount on debenture repurchase ($47,500 payment for $475,000 principal)
  • Strategic reduction of outstanding liabilities strengthening balance sheet
  • Demonstrates effective debt management and capital allocation

Negative

  • $2,598,000 in convertible debentures will still remain outstanding after the transaction

News Market Reaction 1 Alert

+2.74% News Effect

On the day this news was published, TGIFF gained 2.74%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

VANCOUVER, BC / ACCESS Newswire / September 2, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCID:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce that it has entered into a Debenture Repurchase Agreement (the "Agreements") with two arm's length parties (together the "Vendors"), for the repurchase and cancellation of a portion of Company's outstanding unsecured convertible debentures.

Pursuant to the Agreements, the Company will repurchase $475,000 in principal value of debentures for a total cash consideration of $47,500 CAD. Upon closing, the debentures will be transferred, cancelled and removed from the Company's outstanding liabilities.

The Agreement is being conducted in accordance with the provisions of the trust indenture dated December 31, 2023, applicable securities laws, and the policies of the Canadian Securities Exchange (the "CSE").

The Company believes that the repurchase is in the best interest of shareholders and reflects its ongoing commitment to strengthening its balance sheet and reducing its liabilities. Following completion of the repurchase, an aggregate of $2,598,000 in principal value debentures will remain outstanding.

The closing of the repurchase is subject to customary conditions and regulatory approvals, including any required filings with the CSE, and is expected to occur on or around September 5, 2025.

About 1933 Industries Inc.

1933 Industries is a Nevada-based licensed producer, focused on the cultivation and extraction of a large portfolio of cannabis consumer products in a variety of formats under its flagship brands, Alternative Medicine Association (AMA) and Level X. Its product offerings are cultivated at the Company's 68,000 sq. ft. indoor facility and marketed directly to retail dispensaries. AMA branded flower, infused pre-rolls, and in-house boutique concentrates consistently rank as the top products sold in Nevada. For more information, please visit www.1933industries.com

For further information please contact:
Alexia Helgason, VP, Investor Relations
604-728-4407
alexia@1933industries.com

Brian Farrell, Chairman and CEO
brian@1933industries.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on www.sedar.com. 1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE: 1933 Industries Inc.



View the original press release on ACCESS Newswire

FAQ

What is the value of debentures being repurchased by TGIFF in September 2025?

1933 Industries is repurchasing $475,000 in principal value of debentures for a total cash consideration of $47,500 CAD.

How much will TGIFF save through this debenture repurchase?

The company will save approximately $427,500, as it's paying $47,500 CAD to retire $475,000 worth of debt, representing a 90% discount.

When will TGIFF complete the debenture repurchase transaction?

The debenture repurchase transaction is expected to close on or around September 5, 2025, subject to regulatory approvals and CSE requirements.

How many convertible debentures will remain outstanding for TGIFF after this repurchase?

After completing the repurchase, $2,598,000 in principal value debentures will remain outstanding.

What is the purpose of TGIFF's debenture repurchase?

The repurchase aims to strengthen the company's balance sheet and reduce its outstanding liabilities, which management believes is in the best interest of shareholders.
1933 Inds

OTC:TGIFF

TGIFF Rankings

TGIFF Latest News

TGIFF Stock Data

4.41M
449.47M
7.22%
0.01%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Canada
Vancouver